Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Antiviral Therapy
|
April 29, 2022
Comparison of three galenic forms of lamivudine in young West African children living with Human Immunodeficiency Virus
Claire Pressiat, Evelyne Dainguy, Jean-Marc Tréluyer, et al.
Nature Communications
|
December 14, 2020
Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system
Grégoire Chevalier, Eleni Siopi, Laure Guenin-Macé, et al.
Journal of Medicinal Chemistry
|
October 5, 2023
Structure-Based Design of a Lead Compound Derived from Natural Schweinfurthins with Antitumor Properties That Target Oxysterol-Binding Protein
Gwenaëlle Jézéquel, Céline Rampal, Carole Guimard, et al.
Annals of the Rheumatic Diseases
|
June 25, 2018
Methotrexate and BAFF interaction prevents immunization against TNF inhibitors
Samuel Bitoun, Gaetane Nocturne, Bineta Ly, et al.
Iscience
|
December 1, 2025
Persistent myeloid cell reprogramming despite miltefosine treatment in leishmania-infected macaques
Morgane Picard, Steven Boutrais, Vasco Rodrigues, et al.
European Journal of Medicinal Chemistry
|
December 5, 2017
A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation
Timothée Naret, Jérôme Bignon, Guillaume Bernadat, et al.
Nature Communications
|
July 29, 2022
TRIM28-dependent SUMOylation protects the adult ovary from activation of the testicular pathway
Moïra Rossitto, Stephanie Déjardin, Chris M Rands, et al.
European Journal of Medicinal Chemistry
|
April 16, 2021
Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)
Eugénie Romero, Saoussen Oueslati, Mohamed Benchekroun, et al.
Theranostics
|
October 14, 2020
A snake toxin as a theranostic agent for the type 2 vasopressin receptor
Laura Droctové, Manon Lancien, Vu Long Tran, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
June 18, 2025
Novel purine derivatives mitigate hypoxia ischemia related brain injury through agrin, zyxin and synaptotagmin proteins
Aloïse Mabondzo, Clémence Disdier, Amal Bouzid, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Antiviral Therapy
|
April 29, 2022
Comparison of three galenic forms of lamivudine in young West African children living with Human Immunodeficiency Virus
Claire Pressiat, Evelyne Dainguy, Jean-Marc Tréluyer, et al.
Nature Communications
|
December 14, 2020
Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system
Grégoire Chevalier, Eleni Siopi, Laure Guenin-Macé, et al.
Journal of Medicinal Chemistry
|
October 5, 2023
Structure-Based Design of a Lead Compound Derived from Natural Schweinfurthins with Antitumor Properties That Target Oxysterol-Binding Protein
Gwenaëlle Jézéquel, Céline Rampal, Carole Guimard, et al.
Annals of the Rheumatic Diseases
|
June 25, 2018
Methotrexate and BAFF interaction prevents immunization against TNF inhibitors
Samuel Bitoun, Gaetane Nocturne, Bineta Ly, et al.
Iscience
|
December 1, 2025
Persistent myeloid cell reprogramming despite miltefosine treatment in leishmania-infected macaques
Morgane Picard, Steven Boutrais, Vasco Rodrigues, et al.
European Journal of Medicinal Chemistry
|
December 5, 2017
A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation
Timothée Naret, Jérôme Bignon, Guillaume Bernadat, et al.
Nature Communications
|
July 29, 2022
TRIM28-dependent SUMOylation protects the adult ovary from activation of the testicular pathway
Moïra Rossitto, Stephanie Déjardin, Chris M Rands, et al.
European Journal of Medicinal Chemistry
|
April 16, 2021
Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)
Eugénie Romero, Saoussen Oueslati, Mohamed Benchekroun, et al.
Theranostics
|
October 14, 2020
A snake toxin as a theranostic agent for the type 2 vasopressin receptor
Laura Droctové, Manon Lancien, Vu Long Tran, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
June 18, 2025
Novel purine derivatives mitigate hypoxia ischemia related brain injury through agrin, zyxin and synaptotagmin proteins
Aloïse Mabondzo, Clémence Disdier, Amal Bouzid, et al.
Page
of 7